Search Results 1101-1110 of 16988 for monoclonal antibody

1. Center for Multiple Sclerosis and Autoimmune Neurology Research Procedures - Mayo Clinic

   About this study. The purpose of this study is to find and identify autoreactive lymphocytes including autoantibody producing B cells and autoreactive ...

2. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer - Mayo Clinic

   For this reason and because HER2 antibody conjugated to a ... monoclonal antibodies. Patients receiving any medications or substances that ...

3. Influenza virus vaccine recombinant (intramuscular route) - Mayo Clinic

   The vaccine works by causing your body to produce its own protection (antibodies) against the disease. It is also known as a “flu shot". Influenza is a ...

4. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Ongoing treatment with other monoclonal antibodies (e.g., infliximab, rituximab), immunomodulators (eg, abatacept, methotrexate, azathioprine, cyclosporine) ...

5. Low blood cell counts: Side effects of cancer treatment - Mayo Clinic

   Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI · Muscle pain · Needle biopsy · Night sweats · No ...

6. Patient Stories - Laboratory Medicine and Pathology - Mayo Clinic

   Patient stories · Comprehensive testing leads to targeted treatment for rare autoimmune encephalitis antibody · FISH testing helps detect unseen cancer cells.

7. An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients - Mayo Clinic

   Complement activation after binding of an IgG autoantibody ... monoclonal IgG that neutralises the complement protein C5--in neuromyelitis optica spectrum ...

8. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

   ... antibody (HBcIgM Ab), hepatitis B surface antigen (HBsAg) and hepatitis C antibody screen (HCV Ab Scrn) w/reflex testing are required at screening for all ...

9. A Study to Evaluate Larotrectinib to Treat Patients with Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

   Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to grade ≤ 1.

10. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

    ... monoclonal antibody (mAb) targeting MET (such as onartuzumab [MetMAb]); The subject has received radionuclide treatment =< 6 weeks of the first dose of study ...